Mounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...

The new deal builds on existing collaborations between the two companies, which struck a software licensing agreement in 2023, according to...

Eli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will be sold under ...

Eli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in Jul...

The sales team was informed of the decision at a virtual town hall organised last week in conjunction with the media announcement of the de...

Baricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...

The company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...

As part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...

According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for m...

Unlike other foreign drugmakers, it plans to stay away from acquisition of local firms or branded generics to boost its market share.

HCL and Eli Lilly entered into a partnership for developing technologies & improving operational efficiencies to enhance latter's global co...

Pharma company Jubilant Organosys has extended its four-year-old drug research collaboration with Eli Lilly for another five years.

Sharekhan has recommended ‘buy’ on Cadila Healthcare with a target price of Rs.372. At the current market price of Rs272, the stock is avai...

Zydus Cadila eyes large chunk of revenue generation from its new drug discovery pact with global drug giant Eli Lilly.

Suven Life Sciences has entered into an agreement with Eli Lilly to collaborate on the pre-clinical research of molecules in the therapeuti...

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...